An integrated network of microRNA and gene expression in ovarian cancer

BMC Bioinformatics

Volumn 16, Issue 5, 2015, Pages

  Quitadamo, Andrew ^a   Tian, Lu ^a   Hall, Benika ^a   Shi, Xinghua ^a  

^a University of North Carolina at Charlotte   (United States)

Author keywords

Cancer genomics; Expression Quantitative Trait Loci (eQTL) analysis; Integrated network; MicroRNA; Ovarian cancer

Indexed keywords

ASSOCIATION REACTIONS; COMPLEX NETWORKS; DISEASES; GENE EXPRESSION; GENES; PROTEINS;

CANCER GENOMICS; INTEGRATED NETWORKS; MICRORNAS; OVARIAN CANCERS; QUANTITATIVE TRAIT LOCUS;

RNA;

MESSENGER RNA; MICRORNA;

FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORK; GENETICS; HUMAN; OVARY TUMOR;

FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REGULATORY NETWORKS; HUMANS; MICRORNAS; OVARIAN NEOPLASMS; RNA, MESSENGER;

EID: 84961528910     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-16-S5-S5     Document Type: Article

References (62)

1. Siegel R, Ma J, Zou Z, Jemal A: Cancer statistics, 2014. CA: A Cancer Journal for Clinicians. 2014, 64: 9-29. 10.3322/caac.21208.
2. Howlader N, Noone AM, Krapcho M, Neyman N, Aminou R, Altekruse SF, Kosary CL, Ruhl J, Tatalovich Z, Cho H, Mariotto A, Eisner MP, Lewis DR, Chen HS, Feuer EJ, Cronin KA: SEER Cancer Statistics Review. 1975-2009 (Vintage 2009 Populations). National Cancer Institute. Bethesda, MD
3. Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV, Cheng JQ: MicroRNA Expression Profiling in Human Ovarian Cancer: miR-214 Induces Cell Survival and Cisplatin Resistance by Targeting PTEN. Cancer Res. 2008, 68: 425-433. 10.1158/0008-5472.CAN-07-2488.
4. Bentwich I, Avniel A, Karov Y, Aharonov R, Gilad S, Barad O, Barzilai A, Einat P, Einav U, Meiri E, Sharon E, Spector Y, Bentwich Z: Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet. 2005, 15: 766-770.
5. Lewis BP, Burge CB, Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005, 15: 15-20.
6. LaCroix B, Gamazon ER, Lenkala D, Im HK, Geeleher P, Ziliak D, Cox NJ, Huang RS: Integrative analyses of genetic variation, epigenetic regulation, and the transcriptome to elucidate the biology of platinum sensitivity. BMC Genomics. 2014, 15: 292. 10.1186/1471-2164-15-292.
7. Di Leva G, Garofalo M, Croce CM: MicroRNAs in cancer. Annu Rev Pathol. 2013, 15: 287-314.
8. Bradley BS, Loftus JC, Mielke CJ, Dinu V: Differential expression of microRNAs as predictors of glioblastoma phenotypes. BMC Bioinformatics. 2014, 15: 21. 10.1186/1471-2105-15-21.
9. Buffa FM, Camps C, Winchester L, Snell CE, Gee HE, Sheldon H, Taylor M, Harris AL, Ragoussis J: microRNA-Associated Progression Pathways and Potential Therapeutic Targets Identified by Integrated mRNA and microRNA Expression Profiling in Breast Cancer. Cancer Res. 2011, 71: 5635-5645. 10.1158/0008-5472.CAN-11-0489.
10. Miles GD, Seiler M, Rodriguez L, Rajagopal G, Bhanot G: Identifying microRNA/mRNA dysregulations in ovarian cancer. BMC Research Notes. 2012, 5: 164. 10.1186/1756-0500-5-164.
11. Zadran S, Remacle F, Levine RD: miRNA and mRNA cancer signatures determined by analysis of expression levels in large cohorts of patients. PNAS. 2013, 110 (47): 19160-19165. 10.1073/pnas.1316991110.
12. Volinia S, Croce CM: Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer. PNAS. 2013, 110 (18): 7413-7417. 10.1073/pnas.1304977110.
13. Zhang L, Volinia S, Bonome T, Calind GA, Greshock J, Yang N, Liud CG, Giannakakis A, Alexiou P, Hasegawa K, Johnstone CN, Megraw MS, Adams S, Lassus H, Huang J, Kaur S, Liang S, Sethupathy P, Leminen A, Simossis VA, Sandaltzopoulos R, Naomoto Y, Katsaros D, Gimotty PA, DeMichele A, Huang Q, Butzow R, Rustgi AK, Weber BL, Birrer MJ, Hatzigeorgiou AG, Croce CM, Coukos G: Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. PNAS. 2008, 105 (19): 7004-7009. 10.1073/pnas.0801615105.
14. Parikh Aditya, Lee Christine, Joseph Peronne, Marchini Sergio, Baccarini Alessia, Kolev Valentin, Romualdi Chiara, Fruscio Robert, Shah Hardik, Wang Feng, Mullokandov Gavriel, Fishman David, D'Incalci Maurizio, Rahaman Jamal, Kalir Tamara, Redline Raymond, Brown Brian, Narla Goutham, DiFeo Analisa: microRNA-181a has a critical role in ovarian cancer progression through the regulation of the epithelial-mesenchymal transition. Nat Commun. 2014, 01: 2977-
15. Lu Jun, Getz Gad, Miska Eric, Alvarez-Saavedra Ezequiel, Lamb Justin, Peck David, Sweet-Cordero Alejandro, Ebert Benjamin, Mak Raymond, Ferrando Adolfo, Downing James, Jacks Tyler, Horvitz Robert, Golub Todd: MicroRNA expression profiles classify human cancers. Nature. 2005, 435 (7043): 834-838. 10.1038/nature03702.
16. Cancer Genome Atlas Research Network: Integrated genomic analyses of ovarian carcinoma. Nature. 2011, 474: 609-615. 10.1038/nature10166.
17. Ryan Brid M, Robles Ana I, Harris Curtis C: Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer. 2010, 10 (6): 389-402. 10.1038/nrc2867.
18. Stranger BE, Forrest MS, Clark AG, Minichiello MJ, Deutsch S, Lyle R, Hunt S, Kahl B, Antonarakis SE, Tavare S, Deloukas P, Dermitzakis ET: Genome-wide associations of gene expression variation in humans. PLoS Genet. 2005, 1 (6): e78. 10.1371/journal.pgen.0010078.
19. Stranger BE, Forrest MS, Dunning M, Ingle CE, Beazley C, Thorne N, Redon R, Bird CP, de Grassi A, Lee C, Tyler-Smith C, Carter N, Scherer SW, Tavare S, Deloukas P, Hurles ME, Dermitzakis ET: Relative impact of nucleotide and copy number variation on gene expression phenotypes. Science. 2007, 315 (5813): 848-53. 10.1126/science.1136678.
20. Cheung VG, Spielman RS: Genetics of human gene expression: mapping DNA variants that influence gene expression. Nat Rev Genet. 2009, 10 (9): 595-604. 10.1038/nrg2630. Sep;
21. Li Q, Seo JH, Stranger B, McKenna A, Pe'er I, Laframboise T, Brown M, Tyekucheva S, Freedman ML: Integrative eQTL-based analyses reveal the biology of breast cancer risk loci. Cell. 2013, 152 (3): 633-41. 10.1016/j.cell.2012.12.034. Jan 31;
22. Lappalainen T, Sammeth M, Friedlander MR, Hoen PAC, Monlong J, Rivas MA, Gonzalez-Porta M, Kurbatova N, Griebel T, Ferreira PG, Barann M, Wieland T, Greger L, van Iterson M, Almlof J, Ribeca P, Pulyakhina I, Esser D, Giger T, Tikhonov A, Sultan M, Bertier G, MacArthur DG, Lek M, Lizano E, Buermans HPJ, Padioleau I, Schwarzmayr T, Karlberg O, Ongen H, Kilpinen H, Beltran S, Gut M, Kahlem K, Amstislavskiy V, Stegle O, Pirinen M, Montgomery SB, Donnelly P, McCarthy MI, Flicek P, Strom TM, The Geuvadis Consortium, Lehrach H, Schreiber S, Sudbrak R, Carracedo A, Antonarakis SE, Hasler R, Syvanen AC, van Ommen GJ, Brazma A, Meitinger T, Rosenstiel P, Guigo R, Gut IG, Estivill X, Dermitzakis ET: Transcriptome and genome sequencing uncovers functional variation in humans. Nature. 2013, 501 (7468): 506-11. 10.1038/nature12531.
23. The GTEx Consortium: The Genotype-Tissue Expression (GTEx) project. Nat Genet. 2013, 45 (6): 580-5. 10.1038/ng.2653.
24. Liang L, Morar N, Dixon AL, Lathrop GM, Abecasis GR, Moffatt MF, Cookson WO: A cross-platform analysis of 14,177 expression quantitative trait loci derived from lymphoblastoid cell lines. Genome Res. 2013, 23 (4): 716-26. 10.1101/gr.142521.112.
25. Tian L, Quitadamo A, Lin F, Shi X: Methods for Population Based eQTL Analysis in Human Genetics. Tsinghua Science and Technology. 2014, 19 (6): 624-634.
26. Gamazon ER, Innocenti F, Wei R, Wang L, Zhang M, Mirkov S, Ramirez J, Huang RS, Cox NJ, Ratain MJ, Liu W: A genome-wide integrative study of microRNAs in human liver. BMC Genomics. 2013, 14: 395. 10.1186/1471-2164-14-395. Jun 13;
27. Gamazon ER, Ziliak D, Im HK, LaCroix B, Park DS, Cox NJ, Huang RS: Genetic architecture of microRNA expression: implications for the transcriptome and complex traits. Am J Hum Genet. 2012, 90 (6): 1046-63. 10.1016/j.ajhg.2012.04.023.
28. Kim Seunghak, Xing Eric P: Statistical Estimation of Correlated Genome Associations to a Quantitative Trait Network. PLoS Genetics. 2009, 5 (8): e1000587. 10.1371/journal.pgen.1000587.
29. Lee Seunghak, Zhu Jun, Xing Eric P: Adaptive Multi-Task Lasso: with Application to eQTL Detection. NIPS. 2010
30. Chen X, Shi X, Xu X, Wang Z, Mills RE, Lee C, Xu J: A two-graph guided multi-task lasso approach for eQTL mapping. Proceedings of the 15th International Conference of Artificial Intelligence and Statistics (AISTATS), Journal of Machine Learning Research (JMLR) W&CP. 2012, 22: 208-217.
31. S Lee, EP Xing: Leveraging Input and Output Structures For Joint Mapping of Epistatic and Marginal eQTLs. Bioinformatics, Special Issue of the Proceedings of the International Conference on Intelligent Systems for Molecular Biology (ISMB). 2012, 28 (12): i137-i146.
32. Wei Cheng, Xiang Zhang, Zhishan Guo, Yu Shi, Wei Wang: Graph Regularized Dual Lasso for Robust eQTL Mapping. Bioinformatics, Special Issue of the Proceedings of the International Conference on Intelligent Systems for Molecular Biology (ISMB). 2014, 30 (12): i139-i148.
33. Wang Z, Xu J, Shi X: Finding alternative eQTLs by exploring sparse model space. Journal of Computational Biology. 2014, 21 (5): 385-393. 10.1089/cmb.2014.0026.
34. Papadopoulos GL, Reczko M, Simossis VA, Sethupathy P, Hatzigeorgiou AG: The database of experimentally supported targets: a functional update of TarBase. Nucleic Acids Res. 2009, D155-8. 37 Database
35. Shabalin AA: Matrix eQTL: Ultra fast eQTL analysis via large matrix operations. Bioinformatics. 2012, 28 (10): 1353-1358. 10.1093/bioinformatics/bts163.
36. Rossin EJ, Lage K, Raychaudhuri S, Xavier RJ, Tartar D, Cotsapas C, Daly MJ: Proteins Encoded in Genomic Regions Associated with Immune-Mediated Disease Physically Interact and Suggest Underlying Biology. PLoS Genetics. 2011, 7 (1): e1001273. 10.1371/journal.pgen.1001273.
37. The Cancer Genome Atlas: understanding genomics to improver cancer care. [ http://cancergenome.nih.gov/ ]
38. Raj Towfique, Shulman Joshua, Keenan Brendan, Chibnik Lori, Evans Denis, Bennett David, Stranger Barbara, De Jager Philip: Alzheimer Disease Susceptibility Loci: Evidence for a Protein Network under Natural Selection. Am J Hum Genet. 2012, 90 (4): 720-726. 10.1016/j.ajhg.2012.02.022.
39. Yang L, Neale BM, Liu L, et al: Polygenic transmission and complex neuro developmental network for attention deficit hyperactivity disorder: genome-wide association study of both common and rare variants. Am J Med Genet B Neuropsychiatr Genet. 2013, 162B (5): 419-30.
40. Lage K, Karlberg EO, Storling ZM, Olason PI, Pedersen AG, Rigina O, Hinsby AM, Tumer Z, Pociot F, Tommerup N, Moreau Y, Brunak S: A human phenome-interactome network of protein complexes implicated in genetic disorders. Nat Biotechnol. 2007, 25 (3): 309-16. 10.1038/nbt1295.
41. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T: Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Research. 2003, 13 (11): 2498-504. 10.1101/gr.1239303.
42. Atlas of Genetics and Cytogenetics in Oncology and Haematology. [ http://AtlasGeneticsOncology.org ]
43. Wall DP, Pivovarov R, Tong M, Jung JY, Fusaro VA, DeLuca TF, Tonellato PJ: Genotator: a disease-agnostic tool for genetic annotation of disease. BMC Med Genomics. 2010, 3: 50. 10.1186/1755-8794-3-50.
44. Testa JR, Bellacosa A: AKT plays a central role in tumorigenesis. PNAS. 2001, 98 (20): 10983-10985. 10.1073/pnas.211430998.
45. Hanrahan AJ, Schultz N, Westfal ML, Sakr RA, Giri DD, Scarperi S, Janikariman M, Olvera N, Stevens EV, She QB, Aghajanian C, King TA, de Stanchina E, Spriggs DR, Heguy A, Taylor BS, Sander C, Rosen N, Levine DA, Solit DB: Genomic complexity and AKT dependence in serous ovarian cancer. Cancer Discov. 2012, 2 (1): 56-67. 10.1158/2159-8290.CD-11-0170.
46. Dunbier AK, Anderson H, Ghazoui Z, Lopez-Knowles E, Pancholi S, Ribas R, Drury S, Sidhu K, Leary A, Martin L, Dowsett M: ESR1 Is Co-Expressed with Closely Adjacent Uncharacterised Genes Spanning a Breast Cancer Susceptibility Locus at 6q25.1. PLoS Genet. 7 (4): e1001382-
47. Robinson DR, Wu YM, Vats P, Su F, Lonigro RJ, Cao X, Kalyana-Sundaram S, Wang R, Ning Y, Hodges L, Gursky A, Siddiqui J, Tomlins SA, Roychowdhury S, Pienta KJ, Kim SY, Roberts JS, Rae JM, Van Poznak CH, Hayes DF, Chugh R, Kunju LP, Talpaz M, Schott AF, Chinnaiyan AM: Activating ESR1 mutations in hormone-resistant metastatic breast cancer. Nature Genetics. 2013, 1446-1451. 45
48. Darb-Esfahani S, Wirtz1 RM, Sinn BV, Budczies J, Noske A, Weichert W, Faggad A, Scharff A, Sehouli J, Oskay-Ozcelik G, Zamagni C, De Iaco P, Martoni A, Dietel M, Denkert C: Estrogen receptor 1 mRNA is a prognostic factor in ovarian carcinoma: determination by kinetic PCR in formalin-fixed paraffin-embedded tissue. Endocrine-Related Cancer. 2009, 16: 1229-1239. 10.1677/ERC-08-0338.
49. Reimer D, Sadr S, Wiedemair A, Stadlmann S, Concin N, Hofstetter G, Moller-Holzner E, Marth C, Zeimet AG: Clinical Relevance of E2F Family Members in Ovarian Cancer, An Evaluation in a Training Set of 77 Patients. Clin Cancer Res. 2007, 13: 144. 10.1158/1078-0432.CCR-06-0780.
50. D'Souza T, Becker KG, Wood WH, Zhang Y, Wersto RP, Morin PJ: Non-Steroidal Anti-inflammatory Drugs Decrease E2F1 Expression and Inhibit Cell Growth in Ovarian Cancer Cells. PLoS ONE. 2013, 8 (4): e61836. 10.1371/journal.pone.0061836.
51. Lu M, Zhang Q, Deng M, Miao J, Guo Y, Gao W, Cui Q: An analysis of human microRNA and disease associations. PLoS One. 2008, 3 (10): e3420. 10.1371/journal.pone.0003420.
52. Xie B, Ding Q, Han H, Wu D: miRCancer: a microRNA-cancer association database constructed by text mining on literature. Bioinformatics. 2013, 29 (5): 638-644. 10.1093/bioinformatics/btt014.
53. Ruepp A, Kowarsch A, Schmidl D, Buggenthin F, Brauner B, Dunger I, Fobo G, Frishman G, Montrone C, Theis FJ: PhenomiR: a knowledgebase for microRNA expression in diseases and biological processes. Genome Biology. 2010, 11: R6. 10.1186/gb-2010-11-1-r6.
54. Bruno AE, Li L, Kalabus JL, Pan Y, Yu A, Hu Z: miRdSNP: a database of disease-associated SNPs and microRNA target sites on 3'UTRs of human genes. BMC Genomics. 2012, 13 (1): 44. 10.1186/1471-2164-13-44.
55. Jiang Q, Wang Y, Hao Y, Juan L, Teng M, Zhang X, Li M, Wang G, Liu Y: miR2Disease: a manually curated database for microRNA deregulation in human disease. Nucleic Acids Res. 2009, 37: D98-104. 10.1093/nar/gkn714.
56. miRPD. [ http://mirpd.jensenlab.org/HTML/miRPD ]
57. Marchini S, Cavalieri D, Fruscio R, Calura E, Garavaglia D, Nerini IF, Mangioni C, Cattoretti G, livio L, Beltrame L, Katsaros D, Scarampi L, Menato G, Perego P, Chiorino G, Buda A, Romualdi C, D'Incalci M: Association between miR-200c and the survival of patients with stage I epithelial ovarian cancer: a retrospective study of two independent tumour tissue collections. The Lancet Oncology. 2011, 12 (3): 273-285. 10.1016/S1470-2045(11)70012-2.
58. Prislei S1, Martinelli E, Mariani M, Raspaglio G, Sieber S, Ferrandina G, Shahabi S, Scambia G, Ferlini C: MiR-200c and HuR in ovarian cancer. BMC Cancer. 2013, 13: 72. 10.1186/1471-2407-13-72.
59. Cittelly DM, Dimitrova I, Howe EN, Cochrane DR, Jean A, Spoelstra NS, Post MD, Lu X, Broaddus RR, Spillman MA, Richer JK: Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel. Mol Cancer Ther. 2012, 11 (12): 2556-2565. 10.1158/1535-7163.MCT-12-0463.
60. Delfino KR, Rodriguez-Zas SL: Transcription Factor-MicroRNA-Target Gene Networks Associated with Ovarian Cancer Survival and Recurrence. PLoS ONE. 2013, 8 (3): e58608. 10.1371/journal.pone.0058608.
61. Li J, Liang S, Yu H, Zhang J, Ma D, Lu X: An inhibitory effect of miR-22 on cell migration and invasion in ovarian cancer. Gynecol Oncol. 2010, 119 (3): 543-8. 10.1016/j.ygyno.2010.08.034.
62. Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C, Jensen LJ: STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 2013, D808-15. 41 Database